The vaccine slowed the progression of prion disease in the remaining 70 % of the experimental mice, allowing them to live longer than control mice, which did not receive the vaccine and died within about 200 days following infection.
Not exact matches
This is the first time that a virus - based
vaccine has successfully
slowed the
progression of prion disease, says Federoff.
Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests that the
vaccine primed the patients» immune systems to attack tumor cells and helped
slow the cancer's
progression.
Alessandro Sette, Ph.D., a
vaccine biologist at LJI, is investigating factors that foment the immune response in PD in hopes of targeting them to
slow disease
progression.